Parkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by the progressive loss of dopaminergic neurons in substantia nigra. The underlying mechanisms of PD pathogenesis have not been fully illustrated and currently PD remains incurable. Accumulating evidences suggest that mitochondrial dysfunction plays pivotal role in the dopaminergic neuronal death. Therefore, discovery of novel and safe agent for rescuing mitochondrial dysfunction would benefit PD treatment. Here we demonstrated for the first time that α-Arbutin (Arb), a natural polyphenol extracted from Ericaceae species, displayed significant protective effect on the rotenone (Rot)-induced mitochondrial dysfunction and apoptosis of human neuroblastoma cell (SH-SY5Y). We further found that the neuroprotective effect of Arb was associated with ameliorating oxidative stress, stabilizing of mitochondrial membrane potential, and enhancing adenosine triphosphate production. To investigate the underlying mechanism, we checked the AMP-activated protein kinase and autophagy pathway and we found that both were involved in the neuroprotection of Arb. Moreover, we explored the protective effect of Arb in drosophila PD model and found that Arb rescued parkin deficiency-induced motor function disability and mitochondrial abnormality of drosophila. Taken together, our study demonstrated that Arb got excellent neuroprotective effect on PD models both in vitro and in vivo and Arb might serve as a potent therapeutic agent for the treatment of PD.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Abousleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006). Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nature Reviews Neuroscience,7(3), 207–219.
Arsikin, K., Kravic-Stevovic, T., & Jovanovic, M. (2012). Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells. Biochimica et Biophysica Acta,1822(11), 1826–1836.
Auciello, F. R., Ross, F. A., Ikematsu, N., & Hardie, D. G. (2014). Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and/or ADP. FEBS Letters,588(18), 3361–3366.
Ball, N., Teo, W. P., Chandra, S., & Chapman, J. (2019). Parkinson’s disease and the environment. Front Neurol,10, 219.
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2009). Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis. Biochimica et Biophysica Acta,1792(7), 651–663.
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004). Neurodegenerative disease and oxidative stress. Nature Reviews Drug Discovery,3(3), 205–214.
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience,3(12), 1301–1306.
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., & Jeon, S. (2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science,357(6357), 1255–1261.
Dauer, W., & Przedborski, S. (2003). Parkinson’s disease: Mechanisms and models. Neuron,39(6), 889–909.
Ferretta, A., Gaballo, A., Tanzarella, P., Piccoli, C., Capitanio, N., Nico, B., et al. (2014). Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson’s disease. Biochimica et Biophysica Acta,1842(7), 902–915.
Fu, W., Zhuang, W., Zhou, S., & Wang, X. (2015). Plant-derived neuroprotective agents in Parkinson’s disease. American Journal of Translational Research,7(7), 1189–1202.
Garcia-Jimenez, A., Teruel-Puche, J. A., Berna, J., Rodriguez-Lopez, J. N., Tudela, J., & Garcia-Canovas, F. (2017). Action of tyrosinase on alpha and beta- arbutin: A kinetic study. PLoS ONE,12(5), e0177330.
Ghosh, A., Chandran, K., Kalivendi, S. V., Joseph, J., Antholine, W. E., Hillard, C. J., et al. (2010). Neuroprotection by a mitochondria-targeted drug in a Parkinson’s disease model. Free Radical Biology and Medicine,49(11), 1674–1684.
González-Polo, R. A., Niso-Santano, M., Ortíz-Ortíz, M. A., Gómez-Martín, A., Morán, J. M., García-Rubio, L., et al. (2007). Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicological Sciences,97(2), 448–458.
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003). Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proceedings of the National Academy of Sciences of the United States of America,100(7), 4078–4083.
Hall, A. G. (1999). Review: The role of glutathione in the regulation of apoptosis. European Journal of Clinical Investigation,29(3), 238–245.
Hardie, D. G. (2007). AMP-activated/SNF1 protein kinases, conserved guardians of cellular energy. Nature Reviews Molecular Cell Biology,8(3), 774–785.
Isenberg, J. S., & Klaunig, J. E. (2000). Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicological Sciences,53(2), 340–351.
Katsuragi, Y., Ichimura, Y., & Komatsu, M. (2015). p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS Journal,282(24), 4672–4678.
Kavitha, M., Manivasagam, T., Essa, M. M., Tamilselvam, K., Selvakumar, G. P., Karthikeyan, S., et al. (2014). Mangiferin antagonizes rotenone: Induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells. Neurochemical Research,39(4), 668–676.
Koppula, S., Kumar, H., More, S. V., Lim, H. W., Hong, S. M., & Choi, D. K. (2012). Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease. Molecules,17(10), 11391–11420.
Lim, K. L., & Ng, C. H. (2009). Genetic models of Parkinson disease. Biochimica et Biophysica Acta,1792(7), 604–615.
Liu, C. S., Chen, N. H., & Zhang, J. T. (2006). Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix Salviae miltiorrhizae. Phytomedicine,14(7–8), 492–497.
Liu, C. Q., Deng, L., & Zhang, P. (2013). Screening of high α-arbutin producing strains and production of α-arbutin by fermentation. World Journal of Microbiology and Biotechnology,29(8), 1391–1398.
Moon, Y., Lee, K. H., Park, J. H., Geum, D., & Kim, K. (2005). Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: Protective effect of coenzyme Q (10). Journal of Neurochemistry,93(5), 1199–1208.
Narendra, D., Tanaka, A., Suen, D. F., & Youle, R. J. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. Journal of Cell Biology,183(5), 795–803.
Ng, C. H., Guan, M. S., Koh, C., Ouyang, X., Yu, F., Tan, E. K., et al. (2012). AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson’s disease. Journal of Neuroscience,32(41), 14311–14317.
Park, J. S., Davis, R. L., & Sue, C. M. (2018). Mitochondrial dysfunction in Parkinson’s disease: New mechanistic insights and therapeutic perspectives. Current Neurology and Neuroscience Reports,18(5), 21.
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., et al. (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature,44(7097), 1157–1161.
Poels, J., Spasić, M. R., & Callaerts, P. (2009). Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. BioEssays,31(9), 944–952.
Reed, D. J., & Savage, M. K. (1995). Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status. Biochimica et Biophysica Acta,1271(1), 43–50.
Reinhardt, P., Schmid, B., Burbulla, L. F., Schondorf, D. C., Wagner, L., Glatza, M., et al. (2013). Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell,12(3), 354–367.
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015). Mitochondrial dysfunction and mitophagy in Parkinson’s: From familial to sporadic disease. Trends in Biochemical Sciences,40(4), 200–210.
Schapira, A. H. V. (2008). Mitochondria in the etiology and pathogenesis of Parkinson’s disease. The Lancet Neurology,7(3), 97–109.
Solesio, M., Prime, T., Logan, A., Murphy, M. P., Del Mar Arroyo-Jimenez, M., Jordán, J., et al. (2013). The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson’s disease. Biochimica et Biophysica Acta,1832(1), 174–182.
Sugimoto, K., Nishimura, T., Nomura, K., Sugimoto, K., & Kuriki, T. (2003). Syntheses of arbutin-alpha-glycosides and a comparison of their inhibitory effects with those of alpha-arbutin and arbutin on human tyrosinase. Chemical & Pharmaceutical Bulletin,51(7), 798–801.
Sundararaman, A., Amirtham, U., & Rangarajan, A. (2016). Calcium-oxidant signaling network regulates AMP-activated protein kinase (AMPK) activation upon matrix deprivation. Journal of Biological Chemistry,291(28), 14410–14429.
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017). Selective neuronal vulnerability in Parkinson disease. Nature Reviews Neuroscience,18(2), 101–113.
Talpade, D. J., Greene, J. G., Higgins, D. S., & Greenamyre, J. T. (2000). In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. Journal of Neurochemistry,75(6), 2611–2621.
Tessari, I., Bisaglia, M., Valle, F., et al. (2008). The reaction of alpha-synuclein with tyrosinase: Possible implications for Parkinson disease. Journal of Biological Chemistry,283(24), 16808–16817.
Thomas, B., & Beal, M. F. (2007). Parkinson’s disease. Human Molecular Genetics,16(2), 183–194.
Uribe, P., Villegas, J. V., Boguen, R., Treulen, F., Sánchez, R., Mallmann, P., et al. (2017). Use of the fluorescent dye tetramethylrhodamine methyl ester perchlorate for mitochondrial membrane potential assessment in human spermatozoa. Andrologia. https://doi.org/10.1111/and.12753.
Uttara, B., Singh, A. V., Zamboni, P., & Mahajan, R. T. (2009). Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options”. Current Neuropharmacology,7(1), 65–74.
Wang, X., & Hai, C. (2016). Novel insights into redox system and the mechanism of redox regulation. Molecular Biology Reports,43(7), 607–628.
Wang, C., Lu, R., Ouyang, X., Ho, M. W., Chia, W., Yu, F., et al. (2007). Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. Journal of Neuroscience,27(32), 8563–8570.
Weisova, P., Davila, D., Tuffy, L. P., Ward, M. W., Concannon, C. G., & Prehn, J. H. (2011). Role of 5′-adenosine monophosphate-activated protein kinase in cell survival and death responses in neurons. Antioxidants & Redox Signaling,14(2011), 1863–1876.
Whitworth, A. J., Wes, P. D., & Pallanck, L. J. (2006). Drosophila models pioneer a new approach to drug discovery for Parkinson’s disease. Drug Discovery Today,11(3/4), 119–126.
Xiong, N., Huang, J., Zhang, Z., Zhang, Z., Xiong, J., Liu, X., et al. (2009). Stereotaxical infusion of rotenone: A reliable rodent model for Parkinson’s disease. PLoS ONE,4(11), e7878.
Xiong, N., Long, X., Xiong, J., Jia, M., Chen, C., Huang, J., et al. (2012). Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Critical Reviews in Toxicology,42(7), 613–632.
Zhang, H. A., Gao, M., Zhang, L., Zhao, Y., Shi, L. L., Chen, B. N., et al. (2012). Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H2O2-induced injury by increasing stress tolerance ability. Biochemical and Biophysical Research Communications,421(3), 479–483.
This study was supported from the National Science Foundation of China (Grant Nos. 81672508, 81773802), and Jiangsu Provincial Foundation for Distinguished Young Scholars (BK20170041), Key University Science Research Project of Jiangsu Province (No. 16KJA180004), Natural Science Foundation of Shaanxi Province (2019JM-016), Fundamental Research Funds for the Central Universities and China-Sweden Joint Mobility Project (51811530018).
Conflict of interests
The authors declare no conflict of interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ding, Y., Kong, D., Zhou, T. et al. α-Arbutin Protects Against Parkinson’s Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo. Neuromol Med 22, 56–67 (2020). https://doi.org/10.1007/s12017-019-08562-6
- Parkinson’s disease
- Oxidative stress